Concepedia

Annie-Claire Diserens

AD

Statistics

Publications

3

Citations

1.6K

H-Index

3

Active since

2004

Affiliations

University of Lausanne(Current)

University Hospital of Geneva

Annie-Claire Diserens is an author at University of Lausanne.

Publications per year

2004–2012

3

Publications

3

Clinical Trial Substantiates the Predictive Value of <b> <i>O-6-Methylguanine-DNA Methyltransferase</i> </b> Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

Monika E. Hegi, Annie-Claire Diserens, Sophie Godard et al. · Clinical Cancer Research · 2004 · 782 citations

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

Roger Stupp, Monika E. Hegi, Bart Neyns et al. · Journal of Clinical Oncology · 2010 · 439 citations · Full text

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

Pierre Bady, Davide Sciuscio, Annie-Claire Diserens et al. · Acta Neuropathologica · 2012 · 347 citations · Full text

1–3 of 3